Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SARS-CoV-2-IN-41 (compound 2) is a potent inhibitor of SARS-CoV-2 3CL protease, exhibiting an IC50 of 0.022 µM and demonstrating antiviral efficacy [1].
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約6-8 週間 | ¥ 349,000 |
50 mg | 約6-8 週間 | ¥ 454,500 |
100 mg | 約6-8 週間 | ¥ 574,000 |
説明 | SARS-CoV-2-IN-41 (compound 2) is a potent inhibitor of SARS-CoV-2 3CL protease, exhibiting an IC50 of 0.022 µM and demonstrating antiviral efficacy [1]. |
In vivo | SARS-CoV-2-IN-41, administered intraperitoneally at doses of 50 and 200 mg/kg, exhibits antiviral activity against SARS-CoV-2 infection in mice [1]. |
分子量 | 549.63 |
分子式 | C22H30F3N5O4S2 |
CAS No. | 2920904-06-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
SARS-CoV-2-IN-41 2920904-06-7 Microbiology/Virology SARS-CoV Inhibitor inhibitor inhibit